Literature DB >> 30895640

Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?

Kiril Trpkov1, Sean R Williamson2, Yuan Gao1, Petr Martinek3, Liang Cheng4, Ankur R Sangoi5, Asli Yilmaz1, Cheng Wang6, Pilar San Miguel Fraile7, Delia M Perez Montiel8, Stela Bulimbasić9, Joanna Rogala10, Ondrej Hes3.   

Abstract

AIM: To describe a group of distinct low-grade oncocytic renal tumours that demonstrate CD117 negative/cytokeratin (CK) 7-positive immunoprofile. METHODS AND
RESULTS: We identified 28 such tumours from four large renal tumour archives. We performed immunohistochemistry for: CK7, CD117, PAX8, CD10, AMACR, e-cadherin, CK20, CA9, AE1/AE3, vimentin, BerEP4, MOC31, CK5/6, p63, HMB45, melan A, CD15 and FH. In 14 cases we performed array CGH, with a successful result in nine cases. Median patient age was 66 years (range 49-78 years) with a male-to-female ratio of 1:1.8. Median tumour size was 3 cm (range 1.1-13.5 cm). All were single tumours, solid and tan-brown, without a syndromic association. On microscopy, all cases showed solid and compact nested growth. There were frequent areas of oedematous stroma with loosely arranged cells. The tumour cells had oncocytic cytoplasm with uniformly round to oval nuclei, but without significant irregularities, and showed only focal perinuclear halos. Negative CD117 and positive CK7 reactivity were present in all cases (in two cases there was focal and very weak CD117 reactivity). Uniform reactivity was found for PAX8, AE1/AE3, e-cadherin, BerEP4 and MOC31. Negative stains included CA9, CK20, vimentin, CK5/6, p63, HMB45, Melan A and CD15. CD10 and AMACR were either negative or focally positive; FH was retained. On array CGH, there were frequent deletions at 19p13.3 (seven of nine), 1p36.33 (five of nine) and 19q13.11 (four of nine); disomic status was found in two of nine cases. On follow-up (mean 31.8 months, range 1-118), all patients were alive with no disease progression.
CONCLUSION: Low-grade oncocytic tumours that are CD117-negative/CK7-positive demonstrate consistent and readily recognisable morphology, immunoprofile and indolent behaviour.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  chromophobe renal cell carcinoma; hybrid oncocytic tumour; hybrid tumour; low-grade oncocytic tumour; oncocytoma; unclassified oncocytic tumour; unclassified renal carcinoma

Mesh:

Substances:

Year:  2019        PMID: 30895640     DOI: 10.1111/his.13865

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

1.  Classification of solid renal tumor with oncocytic/eosinophilic cytoplasm: is hybrid oncocytic/chromophobe renal tumor a subtype of oncocytoma, chromophobe renal cell carcinoma, or a distinct tumor entity?

Authors:  Shuji Mikami; Naoto Kuroda; Yoji Nagashima; Chisato Ohe; Hiroyuki Hayashi; Ryuichi Mizuno; Mototsugu Oya; Kaori Kameyama
Journal:  Ann Transl Med       Date:  2019-12

Review 2.  Low-grade oncocytic tumor (LOT) - a new renal entity ready for a prime time: An updated review.

Authors:  Mehdi Mansoor; Farshid Siadat; Kiril Trpkov
Journal:  Histol Histopathol       Date:  2022-02-14       Impact factor: 2.303

3.  Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.

Authors:  Hui-Zhi Zhang; Qiu-Yuan Xia; Shu-Yan Wang; Meng-Jie Shi; Su-Ying Wang
Journal:  Virchows Arch       Date:  2022-01-31       Impact factor: 4.064

Review 4.  [Oncocytic tumours of the kidney-new differential diagnoses].

Authors:  I Polifka; R Ohashi; H Moch
Journal:  Pathologe       Date:  2021-09-01       Impact factor: 1.011

5.  Walking the thin line-Low-grade oncocytic tumor of kidney: An emerging entity.

Authors:  Mayur Parkhi; Debajyoti Chatterjee; Ashwani Kumar; Santosh Kumar
Journal:  Med J Armed Forces India       Date:  2021-05-05

6.  Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.

Authors:  Payal Kapur; Ming Gao; Hua Zhong; Suneetha Chintalapati; Midori Mitui; Spencer D Barnes; Qinbo Zhou; Jeffrey Miyata; Deyssy Carrillo; Venkat S Malladi; Dinesh Rakheja; Ivan Pedrosa; Lin Xu; Lisa Kinch; James Brugarolas
Journal:  Mod Pathol       Date:  2021-09-20       Impact factor: 8.209

7.  FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.

Authors:  Kuo Tong; Zhongliang Hu
Journal:  Virchows Arch       Date:  2020-08-19       Impact factor: 4.064

Review 8.  [Histological subtypes of renal cell carcinoma : Overview and new developments].

Authors:  I Polifka; A Agaimy; H Moch; A Hartmann
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

9.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Sean R Williamson; Anthony J Gill; Ondrej Hes; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-02-01       Impact factor: 7.842

10.  Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.

Authors:  Talia L Fuchs; Fiona Maclean; John Turchini; A Cristina Vargas; Selina Bhattarai; Abbas Agaimy; Arndt Hartmann; Chia-Sui Kao; Carla Ellis; Michael Bonert; Xavier Leroy; Lakshmi P Kunju; Lauren Schwartz; Admire Matsika; Sean R Williamson; Priya Rao; Mukul Divatia; Rosa Guarch; Ferran Algaba; Marcelo L Balancin; Ming Zhou; Hemamali Samaratunga; Isabela Werneck da Cunha; Fadi Brimo; Andrew Ryan; David Clouston; Manju Aron; Marie O'Donnell; Emily Chan; Michelle S Hirsch; Holger Moch; Chun-Yin Pang; Cheuk Wah; Weihua Yin; Joanna Perry-Keene; Asli Yilmaz; Angela Chou; Adele Clarkson; Gerhard van der Westhuizen; Ella Morrison; Jonathan Zwi; Ondrej Hes; Kiril Trpkov; Anthony J Gill
Journal:  Mod Pathol       Date:  2021-12-23       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.